Orexinergic activity modulates altered vital signs and pituitary hormone secretion in experimental sepsis

Critical Care Medicine

Volumn 41, Issue 11, 2013, Pages

  Deutschman, Clifford S ^a   Raj, Nichelle R ^a   McGuire, Erin O ^a   Kelz, Max B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cecal ligation and puncture; Central nervous system; Hypothalamus; Orexin A; Vital signs

Indexed keywords

ANTIBODY; HYPOPHYSIS HORMONE; OREXIN A; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AROUSAL; ARTICLE; BLOOD SAMPLING; BRAIN NERVE CELL; BRAIN TISSUE; BREATHING RATE; C57BL 6 MOUSE; CANNULA; CONTROLLED STUDY; HEART RATE; HORMONE DETERMINATION; HORMONE RELEASE; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; LATERAL BRAIN VENTRICLE; LIGATION; MALE; MOUSE; NEUROMODULATION; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PUNCTURE; SEPSIS; TEMPERATURE; TISSUE PREPARATION; VITAL SIGN;

ANIMALS; BODY TEMPERATURE; DISEASE MODELS, ANIMAL; HEMODYNAMICS; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED C57BL; NEUROPEPTIDES; PITUITARY HORMONES; SEPSIS; TIME FACTORS;

EID: 84887036018     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31828e9843     Document Type: Article

References (43)

1. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310
2. Iwashyna TJ: Survivorship will be the defining challenge of critical care in the 21st century. Ann Intern Med 2010; 153:204-205
3. Iwashyna TJ, Cooke CR, Wunsch H, et al: Population burden of longterm survivorship after severe sepsis in older Americans. J Am Geriatr Soc 2012; 60:1070-1077
4. Iwashyna TJ, Ely EW, Smith DM, et al: Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 2010; 304:1787-1794
5. Winters BD, Eberlein M, Leung J, et al: Long-term mortality and quality of life in sepsis: A systematic review. Crit Care Med 2010; 38:1276-1283
6. Lazosky A, Young GB, Zirul S, et al: Quality of life after septic illness. J Crit Care 2010; 25:406-412
7. Godin PJ, Buchman TG: Uncoupling of biological oscillators: A complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 1996; 24:1107-1116
8. Vanhorebeek I, Van den Berghe G: The neuroendocrine response to critical illness is a dynamic process. Crit Care Clin 2006; 22:1-15
9. Hotchkiss RS, Opal S: Immunotherapy for sepsis-A new approach against an ancient foe. N Engl J Med 2010; 363:87-89
10. Boomer JS, To K, Chang KC, et al: Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011; 306:2594-2605
11. Sakurai T, Amemiya A, Ishii M, et al: Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998; 92:573-585
12. de Lecea L, Kilduff TS, Peyron C, et al: The hypocretins: Hypothalamusspecific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 1998; 95:322-327
13. Sakurai T, Nagata R, Yamanaka A, et al: Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice. Neuron 2005; 46:297-308
14. Peyron C, Tighe DK, van den Pol AN, et al: Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998; 18:9996-10015
15. Sinton CM: Orexin/hypocretin plays a role in the response to physiological disequilibrium. Sleep Med Rev 2011; 15:197-207
16. López M, Tena-Sempere M, Diéguez C: Cross-talk between orexins (hypocretins) and the neuroendocrine axes (hypothalamic-pituitary axes). Front Neuroendocrinol 2010; 31:113-127
17. Gompf H, Chen J, Sun Y, et al: Halothane-induced hypnosis is not accompanied by inactivation of orexinergic output in rodents. Anesthesiology 2009; 111:1001-1009
18. Paxinos G, Franklin S: The Mouse Brain in Stereotaxic Coordinates. Second edition. San Diego, Elsevier Academic Press, 2004
19. Andrejko KM, Raj NR, Kim PK, et al: IL-6 modulates sepsis-induced decreases in transcription of hepatic organic anion and bile acid transporters. Shock 2008; 29:490-496
20. Verma R, Huang Z, Deutschman CS, et al: Caffeine restores myocardial cytochrome oxidase activity and improves cardiac function during sepsis. Crit Care Med 2009; 37:1397-1402
21. Mieda M, Willie JT, Hara J, et al: Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc Natl Acad Sci USA 2004; 101:4649-4654
22. Kelz MB, Sun Y, Chen J, et al: An essential role for orexins in emergence from general anesthesia. Proc Natl Acad Sci USA 2008; 105:1309-1314
23. Hubbard WJ, Choudhry M, Schwacha MG, et al: Cecal ligation and puncture. Shock 2005; 24(Suppl 1):52-57
24. Estabrooke IV, McCarthy MT, Ko E, et al: Fos expression in orexin neurons varies with behavioral state. J Neurosci 2001; 20:8620-8628
25. Yamanaka A, Beuckmann CT, Willie JT, et al: Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 2003; 38:701-713
26. Abcejo A, Andrejko KM, Ochroch EA, et al: Impaired hepatocellular regeneration in murine sepsis is dependent on regulatory protein levels. Shock 2011; 36:471-477
27. Weiss YG, Tazelaar J, Gehan BA, et al: Adenoviral vector transfection into the pulmonary epithelium after cecal ligation and puncture in rats. Anesthesiology 2001; 95:974-982
28. Iacobone E, Bailly-Salin J, Polito A, et al: Sepsis-associated encephalopathy and its differential diagnosis. Crit Care Med 2009; 37(10 Suppl):S331-S336
29. Oddo M, Carrera E, Claassen J, et al: Continuous electroencephalography in the medical intensive care unit. Crit Care Med 2009; 37:2051-2056
30. Tracey KJ: The inflammatory reflex. Nature 2002; 420:853-859
31. Chavan SS, Huerta PT, Robbiati S, et al: HMGB1 mediates cognitive impairment in sepsis survivors. Mol Med 2012; 18:930-937
32. Zhang W, Sunanaga J, Takahashi Y, et al: Orexin neurons are indispensable for stress-induced thermogenesis in mice. J Physiol (Lond) 2010; 588(Pt 21):4117-4129
33. Zhang W, Zhang N, Sakurai T, et al: Orexin neurons in the hypothalamus mediate cardiorespiratory responses induced by disinhibition of the amygdala and bed nucleus of the stria terminalis. Brain Res 2009; 1262:25-37
34. Ferguson AV, Samson WK. The orexin/hypocretin system: A critical regulator of neuroendocrine and autonomic function. Front Neuroendocrinol 2003; 24:41-150.
35. Gaykema RP, Goehler LE: Lipopolysaccharide challenge-induced suppression of Fos in hypothalamic orexin neurons: Their potential role in sickness behavior. Brain Behav Immun 2009; 23:926-930
36. Langhans W: Signals generating anorexia during acute illness. Proc Nutr Soc 2007; 66:321-330
37. Grossberg AJ, Zhu X, Leinninger GM, et al: Inflammation-induced lethargy is mediated by suppression of orexin neuron activity. J Neurosci 2011; 31:11376-11386
38. Hollis JH, Lemus M, Evetts MJ, et al: Central interleukin-10 attenuates lipopolysaccharide-induced changes in food intake, energy expenditure and hypothalamic Fos expression. Neuropharmacology 2010; 58:730-738
39. Eggermann E, Serafin M, Bayer L, et al: Orexins/hypocretins excite basal forebrain cholinergic neurones. Neuroscience 2001; 108:177-181
40. Fadel J, Pasumarthi R, Reznikov LR: Stimulation of cortical acetylcholine release by orexin A. Neuroscience 2005; 130:541-547
41. Kohlmeier KA, Watanabe S, Tyler CJ, et al: Dual orexin actions on dorsal raphe and laterodorsal tegmentum neurons: Noisy cation current activation and selective enhancement of Ca2+ transients mediated by L-type calcium channels. J Neurophysiol 2008; 100:2265-2281
42. Stanley EM, Fadel J: Aging-related deficits in orexin/hypocretin modulation of the septohippocampal cholinergic system. Synapse 2012; 66:445-452
43. Sakurai T, Nagata R, Yamanaka A, et al: Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice. Neuron 2005; 46:297-308